[Outcomes of alternative donor allogeneic hematopoietic stem cell transplantation for Fanconi anemia: a five cases report]

Zhonghua Nei Ke Za Zhi. 2018 Jan 1;57(1):54-56. doi: 10.3760/cma.j.issn.0578-1426.2018.01.010.
[Article in Chinese]

Abstract

Five patients with Fanconi anemia who received hematopoietic cell transplantation were retrospectively analyzed. The conditioning regimens included fludarabine, cyclophosphamide and anti-thymocyte globulin. Two patients received both bone marrow and peripheral blood stem cells as the source of stem cell grafts from haploidentical matched related donors, while the others received peripheral blood stem cells from unrelated donors. All patients tolerated well and reached hematopoietic reconstitution. One patient died of intracranial infection. During follow-up, 4 patients survived independent of transfusion with full donor chimerism.

回顾性分析采用氟达拉滨(FLU)+环磷酰胺(CY)+抗胸腺免疫球蛋白(ATG),即FCA预处理方案,并行替代供者造血干细胞移植治疗范可尼贫血的疗效及安全性。2例采用单倍体相合骨髓联合外周血干细胞移植,3例采用非血缘供者外周血干细胞移植。患者耐受性良好,移植后均达到迅速造血重建,1例死于颅内感染,4例存活者均已脱离输血支持且保持完全供者嵌合。.

Keywords: Fanconi anemia; Haploidentical; Hematopoietic stem cell transplantation; Matched unrelated donor.

Publication types

  • Case Reports

MeSH terms

  • Antilymphocyte Serum / administration & dosage
  • Antilymphocyte Serum / therapeutic use
  • Bone Marrow
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Fanconi Anemia / therapy*
  • Graft vs Host Disease / prevention & control*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Retrospective Studies
  • Transplantation Conditioning*
  • Treatment Outcome
  • Unrelated Donors
  • Vidarabine / analogs & derivatives

Substances

  • Antilymphocyte Serum
  • Cyclophosphamide
  • Vidarabine
  • fludarabine